The Persian Darou Alborz Research and Technology (PDART) Fund has been established to advance the research and development of new medicines and technologies and commercialize the new ideas for improving the health and technology. PDART Fund was registered in October/19/2011. The PDART Fund is supported by the Government of Iran and Iranian Pharmaceutical companies. The PDART Fund aims to reinforce Iran’s contribution to global health by developing new health technologies through utilizing the highly developed science and technology capacity found at the country’s pharmaceutical companies, universities and research institutions. Also, the PDART Fund will facilitate and fund global R&D of new health technologies through partnership creation, providing grants for promising research. The fund will help bridge the gap between basic research and commercialization accelerating the development of unprecedented medicines and medical instruments in the developing world.